(Q45052998)

9 December 2017

title

Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profile (English)

1 reference

9 December 2017

Tsuyoshi Hirose

1

1 reference

9 December 2017

Yasufumi Uwahodo

2

1 reference

9 December 2017

Sakiko Yamada

3

1 reference

9 December 2017

Takashi Miwa

4

1 reference

9 December 2017

Tetsuro Kikuchi

5

1 reference

9 December 2017

Hisashi Kitagawa

6

1 reference

9 December 2017

Kevin D Burris

7

1 reference

9 December 2017

C Anthony Altar

8

1 reference

9 December 2017

Toshitaka Nabeshima

9

1 reference

9 December 2017

language of work or name

English

0 references

publication date

1 September 2004

1 reference

Journal of Psychopharmacology

9 December 2017

published in

1 reference

9 December 2017

volume

18

1 reference

9 December 2017

issue

3

1 reference

9 December 2017

page(s)

375-383

1 reference

Alterations of benzodiazepine receptors in type II alcoholic subjects measured with SPECT and [123I]iomazenil

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800308

Typical and atypical antipsychotic occupancy of D2 and S2 receptors: an autoradiographic analysis in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800308

Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800308

Olanzapine: an updated review of its use in the management of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800308

Recent advances in the pharmacotherapy of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800308

Broad therapeutic uses of atypical antipsychotic medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800308

Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800308

The dorsal and medial raphe projections to the substantia nigra in the rat: electrophysiological, biochemical and behavioural observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800308

Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800308

The central 5-HT1A receptors: pharmacological, biochemical, functional, and regulatory properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800308

Atypical antipsychotic-induced diabetes mellitus: how strong is the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800308

Novel antipsychotics and extrapyramidal side effects. Theory and reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800308

The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800308

Serotonin-dopamine interaction and its relevance to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800308

Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800308

A current review of olanzapine's safety in the geriatric patient: from pre-clinical pharmacology to clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800308

Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800308

Olanzapine: an atypical antipsychotic for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800308

Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800308

Receptor reserve at striatal dopamine autoreceptors: implications for selectivity of dopamine agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800308

Effects of drugs acting on cerebral 5-hydroxytryptamine mechanisms on dopamine-dependent turning behaviour in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800308

Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800308

Bodyweight gain associated with atypical antipsychotics: epidemiology and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800308

Schizophrenia: more dopamine, more D2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800308

Comparison of the novel antipsychotic ziprasidone with clozapine and olanzapine: inhibition of dorsal raphe cell firing and the role of 5-HT1A receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800308

The frontal lobes and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800308

7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800308

10.1177/026988110401800308

21 January 2018

Identifiers

DOI

1 reference

9 December 2017

1 reference